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Penicillin Allergy Assessment and
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Antibiotic Stewardship
By Elaine Bailey, PharmD, Mackenzie Connell, Marie Fluent, DDS, and
Erinne Kennedy, DDS, MPH, MMSC

D
Abstract
Antibiotic stewardship is an integral practice for the dental team to ensure a safe dental visit for patients. Now, with
clinical practice guidelines and state toolkits, more dentists
are aware of and actively practicing antibiotic stewardship.
With the application of antibiotic stewardship practices, dentists are identifying the need for additional tools to enhance
practice. For example, one need that has been identified is
a tool for screening patients for true penicillin allergies.
The Penicillin Allergy Assessment Tool (PAAT) is a
decision-making tool that can be used chairside to screen
patients who report an allergy to penicillin. After screening,
dentists can refer and collaborate alongside the health care
team to recommend testing, and confirm the information in
the medical record. If the allergy is confirmed, the health
care team may recommend the use of alternate antibiotics,
and/or desensitization therapy if indicated. For patients who
find that they do not have an allergy, the health care team
can update the documentation in the medical and dental
record(s), and suggest the return to use of first line antibiotics, including beta lactams, when indicated.
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rug-resistant bacteria are a growing threat to public
health, causing 2.8 million infections that result in
upwards of 35,000 mortalities in the United States
each year.1 Dentists rank in the top three prescribers of
antibiotics among health care professionals, and are responsible for approximately 25 million prescriptions yearly.2,3 All antibiotics come with benefits and risks to the
patients; however, some antibiotics are more likely to result in a serious adverse reaction compared to others.
For example, a seven-day course of clindamycin has
164% higher risk of resulting in an opportunistic diarrheal infection from Clostridioides difficile, an infection with a
higher incidence of morbidity and mortality, compared to
a seven-day course of amoxicillin.4 Reports of Clostridioides difficile infections (CDI) occurring in dental patients
are increasing in frequency, often in patients who have
minimal or no additional risk factors for developing CDI.5,6
Often, when dental patients share their allergy to penicillin with their dentist, clindamycin is frequently prescribed as an alternative antibiotic.
Because of the additional risks associated with second-line antibiotics, the Centers for Disease Control and
Prevention encourages all health care professionals to
verify penicillin allergies, with an emphasis on “de-labeling” patients, if appropriate, in an effort to increase the
use of first-line antibiotics.7 The American Academy of Allergy, Asthma & Immunology published updated guidance for the evaluation and management of drug hypersensitivity, including penicillin allergy, in 2020.8 The
evaluation of a penicillin allergy is increasingly being
performed by allergists and other health professionals.
In 2019, the American Dental Association developed
evidence-based clinical practice guidelines for the management of pulpal- and periapical-related dental pain and
intraoral swelling.9 The guidelines introduced broad general principles that apply to the prescribing of antibiotics, and specific prescribing recommendations based on
the diagnosed condition and availability of dental care.
Broadly, antibiotic stewardship practices include:
n Only using antibiotics when they are absolutely necessary.
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n If antibiotics are indicated, prescribe a first line antibiotic when applicable.
n Screening for and confirming
true penicillin allergies.
n Referral for definitive conservative dental treatment (DCDT)
n Recommending the use of overthe-counter (OTC) products for pain
management.
n Discontinuing use of antibiotics
24 hours after the symptoms resolve.
In order to use first-line antibiotics
when indicated, the dental clinic
needs to screen and confirm for true
penicillin allergies. Less than 1% of
the U.S. population has a true IgE mediated allergy that would prevent
them from taking penicillin. While
many adults recount an allergy to
penicillin as a child, that does not
confirm a true allergy at the present
time. Due to waning immunity, it is estimated that approximately 20% of
adults with penicillin allergies will remain allergic after 10 years, and after
20 years fewer than 1% will maintain
their sensitivity.8 Since patients labeled “penicillin allergic” are more
likely to receive second-line antibiotic therapy, the ADA guidelines encourage confirmation or disproof of a
true penicillin allergy. Alternative antibiotics for patients with penicillin
allergy are included in the guidelines
and are summarized in the two chairside guides developed by the ADA.9
The Penicillin Allergy Assessment
Tool (PAAT) is a decision-making tool
developed by the Michigan Antibiotic
Resistance
Reduction
Coalition
(MARR) and the Organization for
Safety and Asepsis Procedures
(OSAP). The tool is intended to be
used by the dental team to evaluate
whether a patient may benefit from
safer antibiotic use by having their
penicillin allergy evaluated by a
health care professional. The tool is
not intended to guide antibiotic
choice, but rather to identify patients
who may benefit by having their penicillin allergy evaluated by a health

care professional, with possible referral to an allergist for penicillin skin
testing. This patient-provider collaborative effort provides a framework
for conversation and opens a gateway
for more effective treatment with fewer adverse effects, including antibiotic resistance.
Dentists can use the MARR/OSAP
Penicillin Allergy Assessment Tool
for patients who present to their dental clinic requiring prophylactic and/
or therapeutic antibiotics who report
a penicillin allergy. The dental team
will review a full medical history, and
a detailed account of the reported allergy signs and symptoms, including
the 4 W’s:
Who — Who reported the allergy?
Was the patient old enough to generate a firsthand account of the allergy?
Did the patient learn this information
from a parent or care-giver if they
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were too young?
What — What happened? Record
the signs, symptoms, and response.
How long did the signs and symptoms last? How severe were they?
What medications or treatments
were provided to resolve the symptoms?
When — When did this happen?
What age? Has it happened since? If
so, how frequently has it happened?
Who — Who confirmed the allergy
signs and symptoms? If so, when?
Based upon medical history review, the dental provider may suggest follow-up with a health care professional. The PAAT tool uses four
categories of signs and symptoms to
help categorize patients during
screening: non-allergy drug side effects (green box); mild to moderate
(yellow box); severe IgE mediated (or(Continued on Page 48)
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(Continued from Page 47)

ange box); and severe Type II-IV (red
box). These are explained below.
Green Box: In a scenario where
symptoms are categorized as side effects rather than an allergic reaction,
yet the electronic health record
(EHR) indicates a penicillin allergy or
unknown allergic status (green box),
a referral to a health care provider for
evaluation is recommended. Further
assessment and an accurate diagnosis would confirm allergic vs. non-allergic symptoms, and may validate or
remove the “penicillin-allergic” label
from the patients’ medical record.
Yellow Box: Mild-to-moderate
rashes that are delayed in onset are
generally not IgE-mediated and often
can be managed by administering
OTC antihistamines. In many cases,
the allergy may have been eliminated
due to waning immunity, especially if
the reaction occurred when the patient was a child and he or she is now
an adult. Follow-up with a health care
professional is advised for accurate
assessment of the reaction, accurate
and current documentation in the
medical record, and recommendation for antibiotic therapy.
Orange Box: IgE-mediated reactions occur immediately or usually
within one hour. Signs and symptoms
may include:
n Hives, which are multiple pink/
red raised areas of skin that are itchy.
n Angioedema or localized edema
without hives affecting the abdomen,
face, extremities, genitalia, oropharynx, or larynx.
n Wheezing and/or shortness of
breath.
n Anaphylaxis, which is a condition diagnosed when the patient experiences signs and symptoms
caused by two or more organ systems
(skin, respiratory, cardiovascular,
GI).7
48

Patients who have a history of IgEmediated reactions have the potential to receive the most benefit by a
complete evaluation by an allergist,
since they are most likely to not receive a first-line antibiotic. As mentioned previously, many of these allergies will have waned, making these
patients candidates for removal of
the drug allergy from the patient
medical record.
Red Box: Severe symptoms occur-

ring more than 72 hours after antibiotic exposure are more accurately labeled “hypersensitivity reactions.”
These include Type II (cytotoxic),
Type III (immune complex), and Type
IV (cell-mediated) reactions. Patients
experiencing these reactions are not
candidates for skin testing since
these reactions are not IgE-mediated.
It is difficult to predict whether patients with a history of delayed hy(Continued on Page 50)

A Chairside Tool Supporting Clinical Antibiotic Stewardship 
The June 2021 issue of the MDA Journal published a
“10-Minute EBD” feature detailing the critical role that the dental
office can play in evaluating purported penicillin allergies. The
author pointed out that many patients labeled “penicillin allergic”
do not have a true allergy. These patients may needlessly receive
an alternative antibiotic therapy that may not be as effective and
pose an increased risk of harm.
A simple penicillin skin test, generally performed by an
allergist, will diagnose the presence or absence of the allergy. If
the allergy is no longer present, the patient’s health record is
updated to reflect the lack of the allergy. This antibiotic
stewardship practice promotes patient safety and informed
decision-making for the consideration of optimal antibiotic
therapy if future infections arise.
In this issue of the Journal, the Michigan Antibiotic Resistance
Reduction (MARR) Coalition, in collaboration with the
Organization for Safety and Asepsis Procedures (OSAP),
provides a tool to support the dental office in referring
appropriate patients for penicillin allergy assessment (see facing
page). Dr. Erinne Kennedy, a member of the expert panel that
developed the ADA guidelines for the use of antibiotics, coauthored the article on these pages describing how the entire
dental team can effectively utilize this tool to ensure a safer
dental visit.
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SHOULD YOUR PATIENT BE REFERRED FOR
PENICILLIN-ALLERGY ASSESSMENT?
USE THIS TOOL TO IDENTIFY PATIENTS WHO MAY BENEFIT FROM HAVING
THEIR PENECILLIN ALLERGY EVALUATED BY A HEALTHCARE PROFESSIONAL.
Who?

Why?

The “Penicillin Allergy Assessment Algorithm” is designed for use by
the dental team.

• Patients who state that they are allergic to penicillin often do not
have a true allergy, or their allergy may have waned over time.1

What?

• Patients labelled as penicillin-allergic are more likely to receive
antibiotics that are NOT recommended as first-line therapy that
have been associated with:

The “Penicillin Allergy Assessment Algorithm” is a decision-making
tool to guide the dental team to identify patients who may benefit
from having their penicillin allergy evaluated by a healthcare
professional with the ultimate goal being to “de-label” the patient as
penicillin allergic--if appropriate.

• More adverse reactions, including C. diff diarrhea which has
been frequently observed in dental patients
• Increased risk for antibiotic resistance

When not?
The framework is NOT intended to provide precise prescribing
recommendations* for individual clinical situations, but rather assist
the clinician and the patient to collaborate and determine if there is
evidence from the patient’s allergy history to
recommend an evaluation.

Patient presents to your dental clinic with
a condition that requires prophylactic or
therapeutic antibiotics and reports a history
of symptoms when taking a penicillin

• Higher healthcare costs
1. J Allergy Clin Immunol Pract. 2020 Oct;8(9S):S16-S116

What signs & symptoms
has the patient experienced
when taking a penicillin?

SEVERE - Type II-IV

SEVERE - IgE Mediated

Steven Johnson Syndrome
Serum Sickness
Toxic Epidermal Necrolysis
Drug Rash Eosinophilia
Systemic Hemolytic Anemia
Drug Fever

Anaphylaxis
Angiodema
Wheezing or shortness of breath
Laryngeal edema
Hypotension
Hives/Urticaria

These are hypersensitivity
reactions, not allergic reactions.
Patients with Type II-IV reactions
should NOT be prescribed
ANY beta-lactam antibiotics
eg. amoxicillin, amoxicillin/
clavulanate (Augmentin),
cephalexin (Keflex).

• Reduced efficacy

Mild to Moderate
Non-immediate onset, nonurticarial mild rash

Recommend re-evaluation of
penicillin allergy by healthcare
professional.

Recommend re-evaluation of
penicillin allergy by healthcare
professional.

Non-Allergy/
Drug Side Effects
Stomach Upset
Nausea
Diarrhea
Abdominal Pain
Headache
Chills
Fatigue

Is the allergy documented in
the patient’s Electronic Health
Record?
No
Do not refer for allergy testing,
document in dental record
that patient does NOT have a
penicillin allergy.

Yes or uncertain
Recommend re-evaluation of
penicillin allergy by healthcare
professional.

*References for antibiotic choices and dosing:
For management of oral pain and swelling: https://ebd.ada.org/en/evidence/guidelines/antibiotics-for-dental-pain-and-swelling
For prophylaxis: https://aaos.webauthor.com/go/auc/terms.cfm?actionxm=Terms&auc_id=224965
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persensitivity reactions will experience similar reactions to penicillin or
other beta-lactams (e.g., cephalosporins, including Keflex) in the future.
Due to this ambiguity and the severity of the reaction, their dental and
medical records should indicate that
they have a delayed hypersensitivity/
allergic reaction, and alternative antibiotics should be considered.
The Penicillin Allergy Assessment
Tool does not include antibiotic recommendations in patients who claim
to have a penicillin allergy; the Chairside Guides included in the ADA
Guidelines are an excellent reference
for antibiotic recommendations.8 In
publishing these guidelines, the guideline panel members recognized the
need for dentists to consider alternative antibiotic choices in patients who
report having a penicillin allergy, as
the evidence around the adverse outcomes associated with clindamycin
has emerged, and the presence of true
allergies remains rare.8
According to these Guidelines, for
patients who have not experienced
anaphylaxis, angioedema, or hives
with penicillin or a related beta-lactam (amoxicillin, ampicillin), the recommended antibiotic is cephalexin
(Keflex). Patients who have experienced the aforementioned symptoms
are candidates for treatment with
azithromycin. The ADA Guidelines include clindamycin as another alternative but caution against its use due to
the associated risk of CDI. Of note,
the American Association of Orthopedic
Surgeons
has
removed
clindamycin entirely as an alternative
treatment in penicillin-allergic patients.10
If the patient decides to have a
suspected penicillin allergy evaluated, his or her primary care provider
will ask a series of questions about

symptoms and possibly refer the patient to an allergist to perform penicillin skin testing. Penicillin skin
testing is a standardized and relatively simple procedure that is frequently performed in hospitalized
patients and is becoming more common in ambulatory settings. There is
a nationally-recognized Penicillin Allergy Assessment and Skin Testing
(PAAST) Certificate program offered
by the University of South Carolina
that supports further expansion of
the service. (See: https://sc.edu/
study/ colleges_schools/pharmacy/
centers/ penicillin_allergy_skin_testing_
certificate_program/index.php).

The collaboration
between the patient
and dental team to
practice antibiotic
stewardship is crucial
to provide safe
dental visits.
Ambulatory locations throughout
Michigan can provide this service.
For example, the Allergy and Asthma
Center of Rochester (aaacr.com) will
evaluate patients for penicillin allergy without a referral. The testing
takes about three hours and the patient will be provided with a letter
containing the results to be shared
with other medical providers. The
testing costs between $500 — $700,
with many insurance companies covering some or all of the expenses.

Healthier, safer care

The goal of penicillin allergy reassessment in the dental office is for clinicians to work collaboratively with
the patient to provide healthier and
safer dental care for the individual
and to improve public health. Safer
antibiotic options would be selected
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in the dental clinic and, more importantly, overall prescribing of broadspectrum antibiotics that have been
associated with the public health
threat of antibiotic resistance would
be decreased. Individuals who may
most benefit from a penicillin allergy
assessment include people with risk
factors for CDI, such as prior CDI infection, older age, recent hospitalization, frequent antibiotic use, and/or
other co-morbidities.
The Penicillin Allergy Assessment
Tool is available on the MARR website (mi-marr.org); laminated copies
may be obtained by emailing info@
mi-marr.org. A copy is also included
along with this article.

and provider specialty in 2011. Clin Infect Dis
2015 May 1;60(9):1308–16.
3. Roberts RM, Bartoces M, Thompson SE,
Hicks LA. Antibiotic prescribing by general
dentists in the United States, 2013. J Am Dent
Assoc 2017 Mar;148(3):172-178.e1.
4. Brown KA, Langford B, Schwartz KL,
Diong C, Garber G, Daneman N. Antibiotic
prescribing choices and their comparative C.
difficile infection risks: a longitudinal casecohort study. Clin Infect Dis
2021;72(5);836–844.
5. Bye M, Whitten T, Holzbauer S. Antibiotic
prescribing for dental procedures in communityassociated Clostridium difficile cases,
Minnesota, 2009–2015. Open Forum Infect Dis
2017 Fall;4(Suppl 1):S1.
6. Peggy Lillis Foundation. At: https://
peggyfoundation.org/.
7. Is it really a penicillin allergy? Centers for
Disease Control and Prevention. At: https://

Summary

The Penicillin Allergy Assessment
Tool presented in this article is one
tool that may effectively reduce unnecessary or sub-optimal antibiotic
use, decrease adverse health effects,
and reduce the potential for infections caused by drug-resistant bacteria. The PAAT can be used to screen
patients who report penicillin allergies and recommend follow-up assessment by a qualified health care
professional.
The collaboration between the patient and dental team to practice antibiotic stewardship is crucial to provide safe dental visits. Utilization of
the outlined tool will provide evidence-based guidance to identify and
guide eligible patients to confirm the
penicillin allergy diagnosis reported
in their medical history so that the
optimal antibiotics can safely be prescribed when needed. 
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